Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelitis NOS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00068055
What this trial is testing

IVIG - West Nile Encephalitis: Safety and Efficacy

Who this might be right for
West Nile Virus
National Institute of Allergy and Infectious Diseases (NIAID) 62
Large-scale testing (Phase 3)Study completedNCT02274285
What this trial is testing

DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants

Who this might be right for
TetanusDiphtheriaPertussis+2 more
Sanofi Pasteur, a Sanofi Company 424
Large-scale testing (Phase 3)Study completedNCT00352963
What this trial is testing

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 480
Testing effectiveness (Phase 2)UnknownNCT06497374
What this trial is testing

FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum DisorderNMO Spectrum Disorder
Tianjin Medical University General Hospital 63
Large-scale testing (Phase 3)Study completedNCT00315055
What this trial is testing

Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule

Who this might be right for
Hepatitis BPolioDiphtheria+1 more
Sanofi Pasteur, a Sanofi Company 310
Testing effectiveness (Phase 2)UnknownNCT04064944
What this trial is testing

Comparison of the Efficacy and Safety of Immunoadsorption and Plasma Exchange for Acute Attack of Refractory Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Third Affiliated Hospital, Sun Yat-Sen University 144
Post-approval studies (Phase 4)Study completedNCT04256252
What this trial is testing

Rituximab at Low dosE for neuromyelitiS optiCa spectrUm disordEr (RESCUE)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Tang-Du Hospital 108
Post-approval studies (Phase 4)Not Yet RecruitingNCT06460545
What this trial is testing

Phase IV Study of Concomitant Administration of the sIPV and HepA

Who this might be right for
PolioHepatitis A
Institute of Medical Biology, Chinese Academy of Medical Sciences 2,000
Large-scale testing (Phase 3)Study completedNCT01340937
What this trial is testing

V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)

Who this might be right for
Bacterial InfectionsVirus Diseases
Merck Sharp & Dohme LLC 2,808
Testing effectiveness (Phase 2)Study completedNCT01457495
What this trial is testing

Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly

Who this might be right for
Hepatitis BDiphtheriaHaemophilus Influenzae Type b (Hib)+3 more
GlaxoSmithKline 312
Not applicableLooking for participantsNCT06885957
What this trial is testing

Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD

Who this might be right for
NMO Spectrum Disorder
Tongji Hospital 200
Large-scale testing (Phase 3)Study completedNCT01577732
What this trial is testing

Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers

Who this might be right for
Acellular PertussisHaemophilus Influenzae Type bTetanus+3 more
GlaxoSmithKline 321
Large-scale testing (Phase 3)Ended earlyNCT02176863
What this trial is testing

Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% Dual Inactivation and Filtration (DIF) in Participants With Post-polio Syndrome

Who this might be right for
Post-polio Syndrome
Instituto Grifols, S.A. 191
Not applicableEnrolling By InvitationNCT06374264
What this trial is testing

Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
MedRhythms, Inc. 30
Not applicableStudy completedNCT01559636
What this trial is testing

Diarrhea and Bivalent Oral Polio Vaccine Immunity

Who this might be right for
SeroimmunityDiarrheaPolio
Centers for Disease Control and Prevention 699
Not applicableStudy completedNCT03368885
What this trial is testing

Evaluation of Integrating MIYCN Interventions in Existing CGPP of PCI

Who this might be right for
Polio
FHI 360 2,590
Large-scale testing (Phase 3)Study completedNCT01337167
What this trial is testing

Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)

Who this might be right for
Bacterial InfectionsVirus Diseases
Merck Sharp & Dohme LLC 1,473
Not applicableStudy completedNCT00260312
What this trial is testing

Study of Inactivated Poliovirus Vaccine Given at an Earlier Schedule With Shorter Intervals

Who this might be right for
Level of Immunity Against Poliovirus Infection
Pan American Health Organization 300
Large-scale testing (Phase 3)Study completedNCT00964028
What this trial is testing

Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib)

Who this might be right for
Haemophilus Influenzae Type bAcellular PertussisDiphtheria+2 more
GlaxoSmithKline 50
Large-scale testing (Phase 3)UnknownNCT04618640
What this trial is testing

To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Boryung Biopharma Co., Ltd. 249
Next Page